MOG and encephalitis: Antibodies against MOG have been associated with a wide variety of clinical phenotypes, including acquired demyelinating syndromes such as optic neuritis, myelitis, acute disseminated encephalomyelitis (ADEM), neuromyelitis optical spectrum disorder (NMOSD), encephalitis, and aseptic meningitis.